Table 2.
Cells impairment and prognostic cells in aNSCLCs.
Tn/Tm | Compared with the NCs | Compared with the Stage Ⅲ | PFS | |||||||
---|---|---|---|---|---|---|---|---|---|---|
All aNSCLCs | Stage Ⅲ | Stage Ⅳ | Stage Ⅳ | % | AC | |||||
% | AC | % | AC | % | AC | % | AC | |||
CD4+ Tn | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ | |
CD4+ Tscm | ★ | ★ | ★ | ★ | ★ | ★ | ||||
CD4+ Tcm | ★ | ★ | ★ | ★ | ★ | ★ | ||||
CD4+ Tem | ★ | ★ | ★ | ★ | ★ | ★ | ★ | |||
CD4+ Tte | ★ | ★ | ||||||||
CD8+ Tn | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ | ★ |
CD8+ Tscm | ★ | ★ | ★ | ★ | ★ | ★ | ★ | |||
CD8+ Tcm | ★ | ★ | ★ | |||||||
CD8+ Tem | ★ | ★ | ★ | ★ | ||||||
CD8+ Tte | ★ | ★ | ★ | ★ | ★ | ★ |
%: percentage; ★: P< 0.05.